MoonLake Immunotherapeutics (MLTX) EPS (Basic) Growth (1y) (2022 - 2026)
Powered by 
Analysis
MoonLake Immunotherapeutics (MLTX) EPS (Basic) Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 87.85% |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 7.59% |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 143.95% |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 322.67% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -16.29% |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 96.41% |
| 10 | MoonLake Immunotherapeutics | 1.10 Bn | 566.16 Mn | - | 5.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.60% |
| Mar 31, 2026 | -52.48% |
| Dec 31, 2025 | -32.47% |
| Sep 30, 2025 | -94.29% |
| Jun 30, 2025 | -124.93% |
| Mar 31, 2025 | -187.49% |
| Dec 31, 2024 | -359.60% |
| Sep 30, 2024 | -164.46% |
| Jun 30, 2024 | -39.36% |
| Mar 31, 2024 | 28.68% |
| Dec 31, 2023 | 71.37% |
| Sep 30, 2023 | 45.62% |
| Jun 30, 2023 | 42.89% |
| Mar 31, 2023 | 90.12% |
| Dec 31, 2022 | 84.52% |
| Sep 30, 2022 | 6.00% |
| Jun 30, 2022 | 82.93% |
| Mar 31, 2022 | -61,366.12% |